We found that high expression of the FSCN1 gene in patients with PIK3CA alterations was associated with worse overall survival (cervical cancer, P = 0.010, Figure 1E; head and neck cancer, P = 0.038, Figure 1F). This evidence concerns the gene FSCN1 and cervical cancer.